No substantial benefit from transplantation reported for a high-risk leukaemia subtype
Checking for minimal residual disease early in treatment can help some young high-risk leukaemia patients…
Browsing: Haematology
New leukaemia drug is more effective and easier to use
A landmark study co-authored by a Loyola Medicine oncologist has found that a newer targeted…
An errant editing enzyme promotes tumour suppressor loss and leukaemia propagation
Writing in the journal Cancer Cell, researchers at University of California San Diego School of Medicine…
Survivors of childhood Hodgkin lymphoma face high long-term risk of solid cancers
New research refines existing evidence that survivors of childhood Hodgkin lymphoma face an elevated risk…
ASH 2018: A first stem cell transplant after CAR T-Cell therapy reduces relapses in ALL
In a new study presented at ASH 2018 in San Diego, patients with ALL who received a…
ASH 2018: Ibrutinib outperforms chemoimmunotherapy in older patients with chronic lymphocytic leukaemia
A new study presented at ASH 2018 shows older patients with chronic lymphocytic leukaemia (CLL) have a…
ASH 2018: Rapid genetic screening shows feasibility of precision medicine for acute myeloid leukaemia
A new study presented at ASH 2018 in San Diego demonstrates it is feasible – and helpful…
ASH 2018: Machine learning-based model improves prognosis accuracy for myelodysplastic syndromes
Researchers have presented at ASH 2018 in San Diego the model of using machine learning – a…
ASH 2018: More than half of patients alive two years after receiving CAR-T therapy for diffuse large B-cell lymphoma in ZUMA-1 trial
A follow-up analysis of patients enrolled in a Phase I/II multi-center trial for diffuse large…
ASH 2018: Daratumumab increases progression-free survival in transplant-ineligible multiple myeloma
Interim results from a large international phase III clinical trial show that adding the immunotherapy…